Author: Charlotte Anthony | Category: In The News | May 12, 2015
Dr. James Lechleiter was featured in San Antonio Business Journal about UTHSCSA's collaboration with Astrocyte Pharmaceuticals.
Under the agreement, Astrocyte Pharmaceuticals will have exclusive use of patent rights for a breakthrough therapeutic approach for brain trauma, such as traumatic brain injury and concussions, owned by the Health Science Center and developed by one of its research scientists, Dr. James Lechleiter.
Lechleiter expects that the scope of the Health Science Center’s research in brain trauma will also expand as Astrocyte Pharmaceuticals advances the neuroprotective therapy discovered in San Antonio.
“Right now, we are focused on the one patent and traumatic brain injury,” Dr. Lechleiter said in the article. “But we envision this also being an effective strategy potentially for strokes and degenerative diseases.”
To read the full article, click here.
Copyright © 2018 The University of Texas Health Science Center at San Antonio
Links provided from the UTHSCSA pages to other websites do not constitute or imply an endorsement of those sites, their content, or products and services associated with those sites.